The once-monthly RNA interference injection medication received FDA approval based on results from the phase II PHYOX2 clinical trial and phase III PHYOX3 extension study.
Researchers evaluated whether patients with atherosclerotic cardiovascular disease (ASCVD) are utilizing high-intensity statins in their routine care of the disease.
Researchers conducted a retrospective analysis of 469 patients with HR+/HER2- metastatic breast cancer and cardiovascular diseases treated with palbociclib plus aromatase inhibitors or aromatase inhibitors...
The results of a recent study presented at the 2023 Hematology/Oncology Pharmacy Association annual conference suggest health care providers should be vigilant about the overutilization of potentially...
Researchers set out to determine the percentage of people in the United States with type 2 diabetes who meet the recommended criteria to use GLP-1 receptor agonists and SGLT-2 inhibitors as well as patients...
The Department of Health and Human Services recommends testing for sexually transmitted infections prior to beginning PrEP for those at-risk of HIV. Researchers examined the prevalence of these infections...
This article summarized a presentation on individualized treatment and medication prescribing for patients with type 2 diabetes by Kathryn Evans Kreider, DNP, at the Practical Updates in Primary Care 2022...
Researchers performed a systematic review and meta-analyses to better understand the relationship between antihypertensive agent use and the risk of Alzheimer disease development.
